Answers are grounded in this paper and cite their sources.
The pathophysiology of malignant intracranial hypertension is a deleterious cycle of increased intracranial pressure, decreased tissue perfusion, declining intracellular energy production, increasing cellular edema, and subsequent increasing intracranial pressure. The use of decompressive craniectomy as a treatment to interdict this cycle, thereby improving outcome, remains controversial. Decompressive craniectomy offers an effective treatment for intracranial hypertension that is refractory to standard medical treatment. In traumatic brain injury, 2 randomized-controlled trials are underway to compare decompressive craniectomy to maximal medical management. In malignant infarction, recent randomized-controlled trials have demonstrated improved clinical outcomes in patients who underwent a decompressive craniectomy, but information on the optimal time-point remains under investigation. Definitive answers as to who will benefit, when to operate, and how the procedure is best carried out, remain as yet to be determined.
No takes yet. Share an insight, caveat, or question.
Toussaint et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: